Chembio Diagnostics Inc (NASDAQ:CEMI) had its Buy rating reiterated by Canaccord Genuity with a $9.00 price target

ME Staff
-
0

Analyst Ratings For Chembio Diagnostics Inc (NASDAQ:CEMI)

Today, Canaccord Genuity reiterated its Buy rating on Chembio Diagnostics Inc (NASDAQ:CEMI) with a price target of $9.00.

There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Chembio Diagnostics Inc (NASDAQ:CEMI) is Buy with a consensus target price of $11.50 per share, a potential 91.67% upside.

Some recent analyst ratings include

  • 3/11/2019-Chembio Diagnostics Inc (NASDAQ:CEMI) had its Buy rating reiterated by Canaccord Genuity with a $9.00 price target
  • 12/19/2018-Chembio Diagnostics Inc (NASDAQ:CEMI) has coverage initiated with a Buy ➝ Buy rating
  • 7/11/2018-Chembio Diagnostics Inc (NASDAQ:CEMI) has coverage initiated with a Buy rating and $14.00 price target
  • On 11/14/2018 John Gary Potthoff, Director, bought 20,000 with an average share price of $5.81 per share and the total transaction amounting to $116,200.00.
  • On 11/5/2018 Robert Passas, Insider, bought 15,000 with an average share price of $6.75 per share and the total transaction amounting to $101,250.00.
  • On 2/13/2018 Neil A Goldman, CFO, bought 14,815 with an average share price of $6.75 per share and the total transaction amounting to $100,001.25.
  • On 6/28/2017 Norman H Pessin, Insider, bought 36,250 with an average share price of $5.48 per share and the total transaction amounting to $198,650.00.
  • On 6/15/2016 Sharon W Klugewicz, COO, sold 3,000 with an average share price of $8.40 per share and the total transaction amounting to $25,200.00.
  • On 6/1/2016 Javan Esfandiari, Insider, sold 25,000 with an average share price of $8.58 per share and the total transaction amounting to $214,500.00.
  • On 5/29/2015 Javan Esfandiari, Insider, sold 20,000 with an average share price of $4.50 per share and the total transaction amounting to $90,000.00.

Recent Trading Activity for Chembio Diagnostics Inc (NASDAQ:CEMI)
Shares of Chembio Diagnostics Inc closed the previous trading session at 6,00 −0,69 10,31 % with shares trading hands.